Hidn.Ns
Hindustan Insecticides Limited (HIDN.NS) is a chemical manufacturing company that produces and sells insecticides and other agrochemical products, primarily generating revenue through the sale of these products to agricultural and pest control markets.
Business. Hindustan Insecticides Limited (HIDN.NS) is a chemical manufacturing company that produces and sells insecticides and other agrochemical products, primarily generating revenue through the sale of these products to agricultural and pest control markets.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Hindustan Insecticides Limited (HIDN.NS) is a chemical manufacturing company that produces and sells insecticides and other agrochemical products, primarily generating revenue through the sale of these products to agricultural and pest control markets.
Hindustan Insecticides Limited maintains a strong liquidity position, with a current ratio of 5.36, indicating that the company has more than five times the current assets to cover its current liabilities. The company's liquidity_fpt score is high, supported by a cash and equivalents balance of INR 60.74 million and a low debt-to-equity ratio of 0.01, suggesting minimal reliance on debt financing.
In terms of profitability, the company's return on equity (ROE) of 7.04% and return on assets (ROA) of 5.95% are in line with the industry's preferred metrics, which emphasize asset efficiency and capital returns. These figures suggest that the company is effectively utilizing its equity and assets to generate returns, though the exact comparison to cohort medians is not available in the provided data.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic detail limits the ability to assess exposure to regional or product-specific risks.
Looking ahead, the company's growth trajectory is supported by a positive operating cash flow of INR 27.46 million and a free cash flow of INR 19.22 million, which provide flexibility for reinvestment or shareholder returns. However, the capital expenditure of INR -23.45 million indicates a reduction in investment in new assets, which may affect long-term growth potential.
The risk assessment for the company is favorable, with low liquidity and dilution risks. No immediate filing-based liquidity or dilution flags were detected, and the company's capital structure remains stable with minimal long-term debt. The dilution potential is also low, with no significant changes in shares outstanding between basic and diluted shares.
Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial snapshot does not include any new product launches, regulatory changes, or strategic acquisitions that would significantly alter its business model or risk profile.
- Hindustan Insecticides Limited has a strong liquidity position with a current ratio of 5.36 and minimal debt.
- The company's ROE and ROA are in line with industry expectations, indicating efficient use of capital and assets.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company's capital expenditure is negative, suggesting a reduction in investment in new assets.
- The risk profile is favorable, with low liquidity and dilution risks and no immediate filing-based flags.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- HIDN.NS Market data — financials · 2026-05-28